NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS

Core Insights - Nutex Health Inc. reported a significant financial turnaround for the fiscal year 2024, with total revenue increasing by 93.8% to $479.9 million compared to $247.6 million in 2023, and net income of $52.1 million compared to a net loss of $45.8 million in the previous year [6][14][17] - The company restated its financial results for the fourth quarter and the entire fiscal year 2024, leading to a net increase in liabilities by $13.4 million (2.9%) and a corresponding decrease in equity by the same amount (6.6%) [4][3] - Adjusted EBITDA for 2024 reached $124.1 million, marking a 1046.1% increase from $10.8 million in 2023, indicating strong operational performance [6][11][22] Financial Performance - Total revenue for the year ended December 31, 2024, was $479.9 million, a 93.8% increase from $247.6 million in 2023 [6][14] - Net income attributable to Nutex Health for 2024 was $52.1 million, compared to a net loss of $45.8 million in 2023 [6][14] - Diluted earnings per share decreased by $0.02 to $9.69 from $9.71, while basic earnings per share also decreased by $0.02 to $10.23 from $10.25 [4][6] Operational Highlights - Total visits at the Hospital Division increased to 168,388 for the year ended December 31, 2024, up 16.9% from 144,058 in 2023 [14] - Revenue from mature hospitals (opened prior to December 31, 2021) increased by 56.6% in 2024 compared to 2023 [14] - Operating income for 2024 was $130.7 million, a significant improvement from an operating loss of $31.8 million in 2023 [14][17] Adjustments and Restatements - The restatement included non-cash adjustments, which had no material effect on key metrics such as revenue, liquidity, and operating cash flow [4][3] - Stock-based compensation expense for the year was $16.6 million, compared to $2.8 million in 2023, with 99% attributed to one-time obligations for under-construction hospitals [14][6] - The company corrected the classification of certain liabilities and reclassified related-party accounts payable balances, impacting the balance sheet structure [7][4] Cash Flow and Liquidity - Net cash from operating activities for the year was $23.2 million, reflecting improved operational efficiency [14][6] - As of December 31, 2024, the company had total assets of $655.3 million, including cash and cash equivalents of $40.6 million [15][14] - The company reported a record high cash balance of $40.6 million, underscoring its financial strength [11][14]